ncontrol trial of targeted therapy on chronic glomerulonephritis
Phase 3
Recruiting
- Conditions
- chronic glomerulonephritis
- Registration Number
- JPRN-UMIN000006080
- Lead Sponsor
- Department of Cardiorenal Medicine, Yokohama City University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with positive serology for hepatitis B, C or HIV, severe renal dysfunction, severe liver dysfunction, pregnant woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method urinalysis, the cumulative dose of prednisolone and the cumulative dose of immunosuppressive drugs
- Secondary Outcome Measures
Name Time Method the adverse effects of prednisolone, the adverse effects of immunosuppressive drugs, the adverse effects of targeted therapy